Folart

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Folart

What is Folart?

Folart is an oral vitamin supplement containing folic acid, a synthetic form of folate. Folate is a water-soluble B-vitamin, specifically vitamin B9, which is naturally present in many foods and is essential for various biological processes in the human body.

Primary Function

The active component in Folart plays a critical role in the synthesis and repair of DNA and RNA. It is a necessary coenzyme for rapid cell division and growth, making it particularly important during periods of increased metabolic activity. It also aids in the production of healthy red blood cells, which transport oxygen throughout the body.

Common Uses

Folart is primarily used to address or prevent conditions related to folate deficiency. This includes:

  • Folate Deficiency Anemia: A condition where the body does not have enough healthy red blood cells due to a lack of folate.
  • Nutritional Support: Supplementation for individuals who may not obtain sufficient folate from their diet.
  • Malabsorption Issues: Support for individuals with certain medical conditions that interfere with the absorption of nutrients from the digestive tract.
  • Preconception and Pregnancy Support: Assisting in the healthy development of the fetal neural tube during early pregnancy.

Mechanism of Action

Once ingested, the body converts folic acid into its metabolically active form, tetrahydrofolate. This molecule acts as a donor of one-carbon units in various metabolic pathways, including the conversion of homocysteine to methionine. By maintaining appropriate folate levels, the body can support cardiovascular health and ensure efficient cellular regeneration.

Regulatory References

  1. WHO Model List of Essential Medicines

What side effects are possible with Folart?

Possible Side Effects and Safety Information

The safety profile for Folart (Folic Acid) is primarily documented in official regulatory sources, with a classification indicating a low incidence of adverse reactions in general use. The most frequently cited effects are formally categorized as Rare in regulatory labeling, meaning they affect less than 1 in 1,000 patients.


Documented Adverse Reactions

Adverse effects listed in official prescribing information primarily involve three system-organ classes:

  • Immune System Disorders: Rare but serious reactions, including generalized allergic sensitization and the potential for severe acute events such as anaphylactic reaction and shock.
  • Gastrointestinal Disorders: These may include symptoms such as anorexia, nausea, abdominal distension, and flatulence.
  • Nervous System / Psychiatric Disorders: Effects such as altered sleep patterns, irritability, difficulty in concentrating, and excitement have been documented.

Critical Safety Constraint

The most significant safety limitation documented by regulatory authorities concerns the use of Folic Acid in patients with untreated Vitamin B12 deficiency (Cobalamin deficiency). Folic Acid supplementation alone is cited as improper therapy in this context because it can correct the blood-related symptoms of megaloblastic anemia while allowing underlying, irreversible neurological damage—specifically subacute combined degeneration of the spinal cord—to progress unmasked. This risk is particularly associated with long-term folate therapy.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory information classifies Folic Acid, the active ingredient in Folart, as having low acute toxicity, meaning acute overdosage is generally unlikely to cause harm [FDA-aligned content]. No specific antidote is known, and treatment for suspected overdose consists of providing symptomatic and supportive measures.

Documented Overdose Manifestations

While acute toxicity is low, high-dose exposure (e.g., 15 mg daily) has been associated with effects such as nausea, abdominal distention, flatulence, and neuro-psychiatric changes like altered sleep patterns and confusion [DailyMed]. Rare instances of severe allergic reactions, including anaphylaxis and bronchospasm, require immediate attention.

When to Seek Urgent Medical Help

Seek emergency medical help immediately if any signs of a severe allergic reaction occur. These signs include hives, rash, difficulty breathing, wheezing, or swelling of the face, lips, tongue, or throat [NIH MedlinePlus-aligned content].

Serious Regulatory Risk

The most serious risk documented in regulatory warnings is associated with chronic, high-dose use that can mask the hematologic symptoms of an undiagnosed Vitamin B12 deficiency. This allows the associated severe neurological damage to progress unchecked and become potentially irreversible [NIH StatPearls].

Therapeutic Uses of Folart

Folart is a brand name for a form of folate, also known as Vitamin B9. Based on its active ingredient, the primary uses relate to addressing nutritional deficiencies and supporting certain physiological processes.


Quick Facts

  • Supports the management of folate deficiency-related anemia (megaloblastic anemia).
  • Contributes to addressing nutritional deficiencies of folate.
  • Assists in supporting healthy red blood cell production.
  • Is utilized to help reduce the risk of certain birth defects (neural tube defects) when taken by women before and during early pregnancy.

What Folart Treats: Main Uses and Benefits

Folart is an intervention used to address and prevent low levels of folate (a B vitamin) in the body. Folate is an essential nutrient for a variety of normal bodily functions, including the generation of new cells.

The medication supports the treatment of megaloblastic anemia, a type of blood condition that is associated with an established deficiency of folate. By supplementing folate levels, it assists in promoting the necessary processes for healthy red blood cell formation.

In the context of pregnancy, supplementation with the active ingredient in Folart contributes to the normal development of the fetus. Taking this supplement before and during the early phases of pregnancy may help reduce the risk of certain serious birth defects affecting the brain and spinal cord, known as neural tube defects.

The use of Folart is intended for individuals who are not consuming or utilizing sufficient amounts of folate from their diet or who have increased physiological requirements.

Eligibility and Restrictions for Use

Folart’s eligibility profile, based on official regulatory labeling, defines specific populations who can and cannot use the medicine.

Who Must Not Use Folart (Contraindications)

Use of Folart is strictly contraindicated for patients with a known hypersensitivity to folic acid or any ingredients. A critical restriction applies to patients with untreated cobalamin (Vitamin B12) deficiency, such as pernicious anemia. Folart must never be used as monotherapy in these cases, as it risks masking the deficiency's progression while allowing irreversible neurological damage.


Who Can Use Folart (Permitted Populations)

Folart is generally approved for use in most adults, children, and infants for the treatment and prevention of folate deficiency. It is explicitly permitted for use by pregnant women for both deficiency treatment and the prevention of Neural Tube Defects, and by breastfeeding women.


Restrictions and Special Considerations

Use is not recommended in patients with malignant disease unless a co-existing folate deficiency is confirmed. Older adults commencing long-term therapy are advised to have their cobalamin status assessed prior to initiation. Patients with malabsorption syndromes are eligible but may require specialized monitoring.

What should I know about interactions with other medicines?

The official interaction profile for Folart (Folic Acid) is defined by regulatory documentation detailing several key pharmacological and substance-based interactions. The profile includes restrictions on co-administration due to the potential for therapeutic antagonism or significant changes in plasma exposure.

Category Interaction Pattern
Exposure Modification Co-administration of Folic Acid is documented to reduce the plasma concentration of certain anticonvulsant medicines, including Phenytoin, Phenobarbital, and Primidone. Conversely, long-term use of these anticonvulsants and drugs like Sulfasalazine may formally reduce the body's Folate levels by interfering with its absorption or metabolism.
Pharmacodynamic Antagonism Folic Acid has a documented antagonistic effect on other anti-folate agents. This specifically applies to Methotrexate, where Folic Acid is officially stated to diminish the therapeutic effects of the co-administered anti-folate drug through metabolic competition.
Timing Requirements To prevent documented interference with Folic Acid absorption, regulatory information requires its administration to be separated in time from bile acid sequestrants like Cholestyramine (typically by 1 hour before or 4–6 hours after) and from Pancreatin (requiring at least two hours separation).
Substance Interference Alcohol consumption is officially documented to interfere with the absorption and subsequent metabolism of Folic Acid.

Interaction Restrictions: The use of Folic Acid is officially restricted in the presence of undiagnosed anemia because Folic Acid may mask the hematological signs of a Vitamin B12 deficiency, potentially allowing neurological progression. High-dose Folic Acid is also restricted in combination with the anti-malarial agent Pyrimethamine due to counteraction of its therapeutic effect.

Mechanism of Action

The mechanism of Folart (Folic Acid) is not based on direct receptor binding but on its function as an essential metabolic precursor that contributes to the necessary components of core cellular machinery. Folart provides the inactive compound, Folic Acid, which must be biologically reduced by the enzyme Dihydrofolate Reductase (DHFR) into THF cofactors. These cofactors act as vital one-carbon donors in the process of nucleotide synthesis, ensuring the production of essential DNA building blocks like dTMP. This molecular action enables the cell to perform correct DNA replication and supports DNA integrity, a function necessary for all cell division. The complete DNA synthesis facilitated by the active folate is critical for the proper and timely maturation of rapidly dividing cells, specifically those within the hematopoietic system. Concurrently, the folate cofactors are required to activate Methionine Synthase, which processes the amino acid homocysteine through re-methylation, converting it back into methionine. This dual action facilitates cellular proliferation and influences systemic metabolic pathways.

Dosage and Administration Information

How Folart is Used

Folart (Folic Acid) administration involves specific routes, standardized dosing, and duration patterns for its use.

Administration and Dosing Principles

Entity Instruction
Route of Administration The oral route (tablets or solution) is the primary method of intake, suitable for most individuals. Parenteral routes (Intramuscular, Subcutaneous, or Intravenous injection) are reserved for specific scenarios involving severe intestinal malabsorption or when oral intake is clinically infeasible.
Standard Dosing Schedule The standard therapeutic regimen for treating deficiency is typically 1 mg once daily. Higher therapeutic doses of 5 mg daily are utilized for certain high-requirement conditions, with regimens reaching up to 15 mg daily when severe malabsorption states are present.
Frequency and Timing The schedule is generally once daily. There are no explicit restrictions on timing relative to meals.
Course Duration Initial treatment for established deficiency states, such as megaloblastic anemia, typically involves a course of approximately four months. This is followed by a potential transition to a daily maintenance dose based on the underlying condition.

Specialized Usage and Administration Notes

A distinct dose is utilized for certain patient populations. For instance, high-risk women planning pregnancy, such as those with a history of neural tube defects, typically use a dose of 5 mg daily beginning before conception and continuing through the first trimester.

In the event a scheduled dose is missed, the standard approach is to skip the missed dose and resume the regular daily schedule. The guidance is not to take a double dose to compensate. The use of Folart is defined by this daily frequency and the conditional adjustment of dose based on the physiological requirement.

Recent Clinical Evidence

Folart: Overview of Studies

Research on Folart (Folic Acid) has primarily explored its use in populations planning or experiencing pregnancy. Multiple studies, including large observational cohorts and short-term randomized trials, have consistently evaluated supplementation during the periconceptional period. This research examines how outcomes related to fetal development evolved in the observed populations, describing patterns related to the risk of neural tube defects (NTDs). Folart was also studied for the management of megaloblastic anemia, a condition characterized by functional imbalance, with findings describing changes measured during the study period.


Beyond deficiency, Folart was observed in studies examining its association with other physiological markers. Research describes patterns related to reducing elevated homocysteine levels, a marker monitored in some cardiovascular research. However, findings related to whether this observed change in homocysteine affects the incidence of long-term cardiovascular events are mixed. Furthermore, Folart was studied for its use alongside certain immunosuppressive medications to help contextualize patient-reported outcomes related to perceived discomfort and managing side effects.


What Remains Uncertain

Evidence remains limited in several key areas. Follow-up durations were limited in most trials, meaning the durability of observed findings is not fully established, and long-term outcomes are not well characterized. Studies exploring Folart's relationship with outcomes related to cognitive function, mood disorders, or various cancer risks have yielded variable results, and certainty remains low. Existing studies provide limited insight into these secondary areas, and comparative evidence is often lacking. Research is ongoing, with clinical trials exploring its effect in high-risk women with conditions associated with acute or disruptive episodes, such as preeclampsia.

Key Studies & References

  1. Folic Acid Supplementation to Prevent Neural Tube Defects: A Limited Systematic Review Update for the U.S. Preventive Services Task Force
  2. Label: FOLIC ACID tablet - DailyMed (FDA-Approved Information)

Frequently Asked Questions (FAQ)

Common questions about Folart (FAQ)


Q: How quickly can a person expect Folart to begin working?

Folart (Folic Acid) supports the body's processes for creating new, healthy red blood cells. When treating an established deficiency, regulatory summaries indicate that the time needed before the measured deficiency correction is observed, which may take a few weeks. This period is related to the necessary process of blood cell regeneration.


Q: What should I do if I forget to take Folart one day?

Regulatory guidance states that a person who misses a dose should skip the missed dose and then resume the regular daily schedule on the next day. Official product information explicitly advises against taking a double dose to compensate for the one that was forgotten.


Q: Does Folart cause any changes in weight?

Weight gain or loss are not listed as documented adverse reactions in official prescribing documents for Folart. While a loss of appetite, known as anorexia, has been reported rarely, this is not a generally cited effect.


Q: Is it normal to feel a mild stomach upset after starting Folart?

Gastrointestinal symptoms are among the documented adverse effects. These may include nausea, flatulence, or abdominal distension. However, these effects are classified in regulatory labeling as rare, which means they are not commonly expected.


Q: What is the maximum duration a person typically uses Folart?

The initial course for treating an established deficiency state is described in official product summaries as approximately four months. Continued use for long-term maintenance depends on the underlying health condition and is determined on an individual basis.


Q: Are there different strengths of Folart available?

Yes, Folart (Folic Acid) is available for prescription in several different strengths. Common dosage forms include 0.4 mg, 1 mg, and 5 mg tablets. The dose provided is determined by a healthcare professional.


Q: Do studies suggest Folart has any impact on energy levels?

Official documentation lists nervous system effects that have been documented, such as 'altered sleep patterns,' 'irritability,' or 'excitement.' These effects are generally associated with higher doses.


Q: Are there specific times of day Folart is usually recommended?

The prescribed schedule for Folart is generally once daily. Official product labeling does not impose explicit restrictions on the time of day a person should take the medicine, and it is also not required to be taken relative to meals.


Q: Is Folart approved for use in children?

Folart (Folic Acid) is generally approved for use in most adults, children, and infants. Specific pediatric dosage recommendations are defined within regulatory guidelines.


Q: What is the definition of 'therapeutic effect' for Folart in trials?

Clinical trials for Folic Acid typically assess endpoints related to its known functions. The therapeutic effect is defined by outcomes such as the correction of blood cell abnormalities in megaloblastic anemia and findings related to the risk of neural tube defects.


Q: Is Folart the same as other similar supplements?

Folart contains Folic Acid, which is the specific synthetic or manufactured form of Vitamin B9. This chemical structure is distinct from the various 'folate' compounds found naturally in foods. Both are used as sources of the essential nutrient.


Q: Are there any common foods to avoid while taking Folart?

Official regulatory information primarily notes that alcohol consumption is documented to interfere with the absorption and subsequent metabolism of Folic Acid in the body. No other common foods are typically restricted in the official labeling.


Q: Can Folart be used by people with kidney issues?

Regulatory guidance does not establish a universal, specific restriction on its use based on routine kidney function. However, specific information regarding use in severe cases, such as in individuals on dialysis, may be included in some regulatory dose information.


Q: Is Folart suitable for people who are vegan or vegetarian?

The active ingredient, Folic Acid, is synthetic. A specific statement on its suitability for vegan/vegetarian diets is not often provided by regulators, but the specific tablet or capsule formulation of Folart may contain inactive ingredients (like fillers or coatings) that individuals can check on the official product label.


Q: Can Folart be used by older adults safely?

Folart is generally permitted for use in older adults. A key special consideration documented in official information is that older adults starting long-term use are cited as needing an assessment of their Cobalamin (Vitamin B12) status to avoid potential progression of an undetected deficiency.


Q: Is Folart considered a long-term treatment?

Folart can be used for long-term maintenance in certain underlying conditions, though initial treatment courses for deficiency are time-limited. Long-term use is cited in regulatory documents as needing an assessment of Vitamin B12 status to avoid potential progression of an undetected deficiency.


Q: What is the difference between Folart and generic versions?

Generic versions of Folic Acid are required by regulatory bodies to contain the same active ingredient at the same strength as the brand-name product, Folart. Differences are typically related to the inactive ingredients, such as the dyes, binders, or fillers used in the final formulation.


Q: Can I take Folart if I already take a daily multivitamin?

Official cautions advise reviewing the labels of all supplements being used, since many daily multivitamin and mineral products already contain Folic Acid. This ensures that the recommended daily amount of Folic Acid is not exceeded.


Q: How is Folart regulated by government health agencies?

The core ingredient, Folic Acid, is internationally recognized on the World Health Organization (WHO) Model List of Essential Medicines. In many countries, products containing Folic Acid are subject to labeling and quality standards for pharmaceutical products.


Q: Does Folart contain lactose or gluten?

Official drug labels list all inactive ingredients. The specific tablet or capsule formulation of Folart may contain inactive ingredients like lactose or gluten, though Folic Acid itself is free of these. Individuals can check the specific product label.


Q: Can a person take Folart if they are fasting?

Official guidance on administration indicates that the prescribed schedule is once daily. The product labeling does not impose explicit restrictions regarding its timing relative to meals, which suggests the medicine can be taken independently of food intake or while fasting.


Q: Is it necessary to take Folart at the exact same time every day?

The overall regimen is based on a once-daily schedule. The official guidance for a missed dose is to skip it and resume the next day as usual, which implies that small, reasonable variations in the exact time of day are not considered critical to the overall effectiveness.


Q: Does Folart carry a 'Black Box' warning?

Official drug labeling for Folic Acid does not contain a 'Black Box' warning. This type of warning is the most serious safety alert required by the FDA to highlight a serious or life-threatening risk associated with a medicine.


Q: Is Folart associated with any risks for people with liver disease?

Regulatory information does not typically contain data regarding the need for liver dose adjustments for Folic Acid. This suggests that major restrictions or dosage changes are not officially established based on routine liver impairment.

How should Folart be stored and disposed of?

How to Store and Dispose of Folart (Folic Acid)

Folart (Folic Acid) must be stored under specific, officially defined conditions to ensure its stability.

Storage Requirements

Condition Regulatory Requirement
Temperature Store at 20 to 25 C (68 to 77 F), with excursions permitted up to 30 C (86 F).
Protection Must be protected from light and moisture to prevent degradation.
Container Keep the medication in a well-closed container or bottle.
Child Safety Store strictly out of the sight and reach of children.

Disposal Instructions

Unused or expired Folart must be discarded according to established state or local guidelines for medicine disposal. Do not dispose of the product in household waste or pour it down a sink or toilet, as mandated by regulatory guidelines on pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Folart found in:

A-Z Index: